Patient Response to Treatment 3x Better When PrismRA Guided Therapy Selection Test Results Informed Treatment Decisions for Three-Quarters of Patients Broad Adoption Could Lead to Significant Clinical Improvements for Rheumatoid Arthritis Patients WALTHAM, Mass. (Feb....
WALTHAM, Mass. (Jan. 6, 2022) - Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, today announced that Alif Saleh, chief executive officer, will present at the 40th Annual J.P. Morgan...
PrismRA enables precision medicine, supports better outcomes, and reduces ineffective utilization of TNFi therapy for rheumatoid arthritis treatment WALTHAM, Mass. (December 6, 2021) – Scipher Medicine, a precision immunology company matching patients with their most...
November 15, 2021 – WALTHAM, Mass. – Scipher Medicine, a precision immunology company matching patients with their most effective medication therapies, today announced a partnership with RxParadigm, a pharmacy benefit manager company delivering...
November 11, 2021 – WALTHAM, Mass. – Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced that Alif Saleh, Chief Executive Officer, and John Strumbos, Chief Financial Officer, will...
